Frederik A Verburg

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Topics

Top Venues

European journal of nuclear medicine and molecular imaging

Clinical endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Frederik A Verburg, Erik de Blois, Stijn Koolen, Mark W Konijnenberg
Replacing Lu-177 with Tb-161 in DOTA-TATE and PSMA-617 therapy: potential dosimetric implications for activity selection. EJNMMI physics 10 (1) (2023)
Alfredo Campennì, Anca M Avram, Frederik A Verburg, Ioannis Iakovou, Heribert Hänscheid, Bart de Keizer, Petra Petranović Ovčariček, Luca Giovanella
The EANM guideline on radioiodine therapy of benign thyroid disease. European journal of nuclear medicine and molecular imaging (2023)
Larissa R Bögershausen, Luca M Giovanella, Thomas Stief, Markus Luster, Frederik A Verburg
Long-term predictive value of highly sensitive thyroglobulin measurement. Clinical endocrinology (2022)
Frederik A Verburg, Glenn Flux, Luca Giovanella, Douglas van Nostrand, Kristoff Muylle, Markus Luster
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade. European journal of nuclear medicine and molecular imaging 47 (1) (2019)
Frederik A Verburg, Luca Giovanella, Ioannis Iakovou, Mark W Konijnenberg, Werner Langsteger, Michael Lassmann, Jasna Mihailovic, Markus Luster
I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth? European journal of nuclear medicine and molecular imaging 45 (13) (2018)
Frederik A Verburg, Uwe Mäder, Markus Luster, Christoph Reiners
The effects of the Union for International Cancer Control/American Joint Committee on Cancer Tumour, Node, Metastasis system version 8 on staging of differentiated thyroid cancer: a comparison to version 7. Clinical endocrinology 88 (6) (2018)
Frederik A Verburg, Markus Luster
A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy. European journal of nuclear medicine and molecular imaging 44 (10) (2017)
Frederik A Verburg, Markus Luster, Luca Giovanella, Michael Lassmann, Carlo Chiesa, Nicolas Chouin, Glenn Flux, null null
The "reset button" revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients. European journal of nuclear medicine and molecular imaging 44 (6) (2017)